Benralizumab for severe DRESS in two COVID-19 patients

J Allergy Clin Immunol Pract. 2021 Jan;9(1):481-483.e2. doi: 10.1016/j.jaip.2020.09.039. Epub 2020 Oct 8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Asthmatic Agents / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • COVID-19 / complications*
  • Drug Hypersensitivity Syndrome / complications*
  • Drug Hypersensitivity Syndrome / drug therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • benralizumab